GlassScriptPhysician profile
Michael Scott Eskew
NPI 1487125282
$5,446.66
in general payments reported to CMS, 2019-2025
45 companies · $894 in 2025
The $894 reported for 2025 was more than what 83% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,316 · 2022: $1,134 · 2023: $1,020 · 2024: $1,082 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,996.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $770.06 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $518.59 | 2021-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $438.28 | 2022-2025 | |
| Novo Nordisk INC | $405.62 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $398.29 | 2021-2024 | Repatha, Otezla, Evenity |
| Axsome Therapeutics, INC. | $219.78 | 2025 | Symbravo |
| Lilly USA, LLC | $210.03 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Janssen Pharmaceuticals, INC | $197.46 | 2024-2025 | Spravato |
| Astrazeneca Pharmaceuticals LP | $166.92 | 2021-2024 | Airsupra |
| Eisai INC. | $151.11 | 2021-2025 | |
| Lundbeck LLC | $145.14 | 2023-2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.31 | 2021-2023 | Jardiance |
| Bausch Health US, LLC | $141.99 | 2023-2024 | Aplenzin, Wellbutrin |
| Takeda Pharmaceuticals U.S.A., INC. | $131.17 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $124.54 | 2021-2023 | Contrave, Onzetra Xsail |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Eskew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.